Skip to main content
OpenTrials
Completed

NCT Number: NCT02619032

Remifentanil and Fentanyl in Dental Surgery (REFEDS)

This study was a prospective comparative study. The purpose of this study was to investigate the hypothesis whether remifentanil compared to fentanyl can induce less inflammatory and stress response to the day-case dental surgery in Persons with special needs (PSN). Secondary aims were to investigate comparatively their effect on patients intraoperative hemodynamic response and postoperative analgesia.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

2nd Department of Anesthesiology, Attikon University Hospital

Athens, Attica, 12462, Greece

About this study

The study included 46 adult patients with cognitive impairment who underwent day-case dental surgery under general anesthesia with propofol aiming to keep a BIS-values range between 40-45. Nasal tracheal intubation was performed in all patients while neuromuscular blockade was achieved by rocuronium 0.6 mg/kg iv and repetitive doses of rocuronium of 10 mg iv, if needed.

Patients were randomly allocated receive for intraoperative analgesia either fentanyl 50 μg iv bolus (group F, n=23) or continuous infusion of remifentanil 0.5-1 μg/kg/min (group R, n=23). Randomization was performed using using a computer-generated randomization schedule.

Intraoperatively, patients in both groups received IV granisetron 3 mg, methylprednisolone 125 mg and clindamycin 600 mg, while atropine 0.02 mg/kg and neostigmine (0.05 mg/kg) was administered to to reverse neuromuscular blockade. Intraoperative monitoring included non-invasive measurement of arterial blood pressure, electrocardiogram, pulse oxymetry, capnography and Bispectral Sedation Index (BIS®).

Postoperatively, patients remained under surveillance in the post-anesthesia care unit [PACU] for 3 h. Postoperative pain was assessed for the first 12 postoperative hours, at 30 min time-intervals for the first 3 hours, and every 3 hours thereafter by an independent observer, blinded to the study group, using the Wong-Baker faces pain rating scale (0-6). If pain scores were ≥3 a rescue dose of paracetamol 12.5 mg/kg iv was administered.

Inflammation markers and stress hormones [cortisol, Tumor necrosis factor (TNF-a), substance-P, melatonin and β-endorphin] were measured in each patient before induction of anesthesia, after tracheal intubation and at the end of operation.

Statistical Analysis was performed using Kolmogorov-Smirnov test, Student's unpaired t-test or Repeated Measures ANOVA with Holm's post-hoc analysis appropriately. A p value less than 0.05 was considered statistically significant.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with cognitive impairment
  • of category II according to the American Society of Anesthesiology (ASA) classification
  • scheduled for elective dental surgery with short duration

Exclusion criteria

  • Patients of more than category II of American Society of Anesthesiology (ASA) classification
  • Prolonged duration of surgery (>1 hour)

Treatment and study plan

Remifentanil

Drug

Intraoperative continuous infusion of remifenatanil. Remifentanil infusion was interrupted upon completion of surgical intervention.

Other names: Ultiva

Fentanyl

Drug

Fentanyl 50 μg iv bolus at the induction of anesthesia and before the start of surgery.

Other names: FNT

Primary outcomes

  1. Change from baseline plasma cortisol values at 1 hour

    Time frame: At 1 hour after the induction of anesthesia and surgery

    Plasma cortisol values were measured with an ELISA kit as mg/dl

  2. Change from baseline plasma tumor necrosis factor-α (TNF-α) values at 1 hour

    Time frame: At 1 hour after the induction of anesthesia and surgery

    Tumor necrosis factor-α (TNF-α) measurement was performed with Elisa immunoenzyme assay as pg/ml

  3. Change from baseline plasma substance-P values at 1 hour

    Time frame: At 1 hour after the induction of anesthesia and surgery

    Substance-P measurement was performed with Elisa immunoenzyme assay as ng/ml

  4. Change from baseline plasma melatonin values at 1 hour

    Time frame: At 1 hour after the induction of anesthesia and surgery

    Melatonin measurement was performed with Elisa immunoenzyme assay as pg/ml

  5. Change from baseline plasma β-endorphin values at 1 hour

    Time frame: At 1 hour after the induction of anesthesia and surgery

    β-endorphin was measured with Elisa immunoenzyme assay as ng/ml

Secondary outcomes

  1. Differences in intraoperative systolic arterial blood pressure values (mm Hg) between the two study groups

    Time frame: 1 hour

    Measurements before the induction of anesthesia (baseline values) and at and 60 min (1 hour) after the induction of anesthesia

  2. Differences in intraoperative heart rate values (bmp) between the two study groups

    Time frame: 1 hour

    Measurements before the induction of anesthesia (baseline values) and at 60 min (1 hour) after the induction of anesthesia

  3. Differences in postoperative pain scores scores between the two study groups

    Time frame: Up to 12 postoperative hours

    Pain was assessed using the Wong-Baker faces pain rating scale (0-6) at 12 postoperative hours

Sponsors and collaborators

Lead sponsor

Attikon Hospital

Other

Collaborators

  • Asklepieion Voulas General Hospital

Registry information

Official study title

Remifentanil vs Fentanyl During Day Case Dental Surgery in Persons With Special Needs: a Comparative Study of Their Effect on Stress Response and Postoperative Pain

Acronym: REFEDS

Important dates

Study start
2005
Primary completion
2009
Study completion
2009
First posted
Dec 2, 2015
Registry last updated
Dec 2, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.